Home Infusion Therapy Global Market Report 2024

Home infusion therapy involves the subcutaneous or intravenous administration of biologicals or drugs to individuals in their homes. This process allows patients to receive medications through catheters or needles, either directly into their veins or under their skin, providing a convenient and comfortable alternative for treatment.

The primary products associated with home infusion therapy include infusion pumps, intravenous sets, IV cannulas, and needleless connectors. Infusion pumps are medical devices designed to deliver medicine into the patient's body in specific and controlled amounts. They regulate the rate at which replacement fluid is infused into the blood outflow line or the blood inflow line. Home infusion therapy can be administered through various routes, including intramuscular, subcutaneous, and epidural, and is utilized in diverse applications such as total parenteral nutrition, anti-infective therapy, enteral nutrition, hydration therapy, chemotherapy, IVIg or specialty pharmaceuticals, and others. The end users of home infusion therapy include patients, nurses, hospitals, and other healthcare providers.

The home infusion therapy market research report is one of a series of new reports that provides home infusion therapy market statistics, including home infusion therapy industry global market size, regional shares, competitors with a home infusion therapy market share, detailed home infusion therapy market segments, market trends and opportunities, and any further data you may need to thrive in the home infusion therapy industry. This home infusion therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The home infusion therapy market size has grown rapidly in recent years. It will grow from $28.68 billion in 2023 to $31.95 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth observed during the historic period in the field of home infusion therapy can be attributed to several factors, including the increased aging population, a rise in patient preference for home-based treatments, a growing prevalence of chronic diseases, and an increased trend towards avoiding hospital stays. These factors collectively contributed to the expansion of home infusion therapy during the historical period.

The home infusion therapy market size is expected to see rapid growth in the next few years. It will grow to $47.43 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period in home infusion therapy can be attributed to various factors, including the increasing integration of telehealth, a growing emphasis on personalized medicine, heightened awareness and preparedness for pandemics, the empowerment of patients, and the rise of value-based care models. Major trends expected during this period include advancements in infusion devices, the use of biologic and specialty drugs, a focus on pediatric home infusion, increased emphasis on infusion pump safety, and enhanced patient education and training.

The home infusion therapy market is poised for growth, fueled by the expanding global population and the subsequent rise in food demand. As the world's population is anticipated to increase by 2 billion people in the next 30 years, reaching 9.7 billion by 2050, there is a parallel projection of a 70% surge in global food demand by 2050. Home infusion therapy, a critical aspect for patients, particularly the aging population, relies on proper nutrition. The increasing number of elderly individuals requiring home infusion therapy aligns with the rising global population and heightened demand for food. This confluence of factors is expected to be a significant driver propelling the growth of the home infusion therapy market.

The home infusion therapy market is expected to experience growth driven by the increasing number of households worldwide. Household infusion therapy offers a safe and familiar environment for patients, particularly those managing chronic conditions, to receive necessary medical treatments. This approach enhances patient comfort and well-being, facilitating effective health management at home. Notably, in the US, there was a 1.53% increase in households from 2021 to 2022, totaling 131.2 million households. Similarly, in Europe, there were 198 million households in 2022, with an average of 2.2 members per household. The growing number of households globally is a significant factor driving the expansion of the home infusion therapy market.

A key trend in the home infusion therapy market is the emergence of strategic partnerships and collaborations among major industry players. Companies operating in the sector are actively engaging in partnerships to strengthen their market position. For example, CarepathRx, a US-based pharmacy and medication management solutions provider, collaborated with Mount Sinai Health System, extending patient access to home infusion therapies across the health system. Additionally, a partnership with the University of Chicago Medicine enabled CarepathRx to deliver comprehensive home and specialty infusion services, expanding UChicago Medicine's clinical reach into home and ambulatory settings. Strategic collaborations are indicative of the industry's commitment to enhancing patient care and broadening the availability of home infusion therapy services.

Major players in the home infusion therapy market are intensifying their efforts to introduce compact infusion systems, exemplified by products like the Avoset Infusion Platform. Launched by Eitan Medical Ltd., an Israel-based medical device company, in April 2023, the Avoset Infusion Platform is a connected, multi-therapy ambulatory infusion system designed to redefine post-acute care and specialty infusion therapy. This compact platform aims to enhance the user experience through simplified technology, offering features like remote monitoring capabilities and integration with the AvosetGo app. These advancements contribute to improved patient outcomes, comfort, and independence throughout the treatment cycle. The focus on introducing innovative and compact infusion systems underscores the industry's commitment to providing effective and user-friendly home infusion therapy solutions.

In March 2021, PromptCare, a significant player in specialty home infusion and complex respiratory services based in the US, bolstered its position in the market through the acquisition of NBN Infusions Inc. This strategic move reinforces PromptCare's commitment to providing specialty infusion therapies. NBN Infusions Inc., a US-based healthcare services provider, offers a range of services, including home infusion therapy, enteral therapy, and respiratory therapy services. The acquisition aligns with PromptCare's goal of expanding its capabilities and service offerings in the dynamic landscape of home infusion therapy. This strategic decision positions PromptCare to address the evolving needs of patients requiring specialty infusion therapies and further solidifies its presence in the home healthcare sector.

Major companies operating in the home infusion therapy market include B. Braun Melsungen AG, Baxter International Inc., Eli Lilly and Company, Fresenius Kabi AG, Option Care Health Inc., CareCentrix Inc., Caesarea Medical Electronics Ltd., JMS Co. Ltd., Terumo Corporation, Smiths Medical ASD Inc., Optum Inc., CVS Health Corporation, KabaFusion Holdings LLC., PromptCare Companies, Nipro Corporation, ICU Medical Inc., Becton Dickinson and Company, Ascension at Home with Compassus, Barnes Healthcare Services Inc., BayCare HomeCare Inc., ARJ Infusion Services Inc., Beacon Infusion Healthcare Services LLC., CarepathRx LLC., Coram CVS Specialty Infusion Services, CSI Pharmacy LLC., Fairview Home Infusion, Healix Infusion Therapy Inc., InfuCare Rx Inc., Integrated Home Care Services Inc., IVX Health Inc., Kroger Specialty Infusion, Metro Infusion Center, National Pharmacy Services LLC., Nations Home Infusion LLC., Oso Home Care LLC., Palmetto Infusion Services LLC., Penn Home Infusion Therapy, The PharmaCare Network Inc., PICC Lines Plus LLC., Premier Infusion Care LLC., Basic Home Infusion Inc.

North America was the largest region in the home infusion therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the home infusion therapy market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the home infusion therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The home infusion therapy market includes revenues earned by entities anti-emetics, catheter maintenance, chemotherapy, hydration, immune globulin therapy, and inotropic therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.